AL amyloidosis treatment including stem cell transplantation

Mayo Clinic hematologist Angela Dispenzieri, M.D., discusses immunoglobulin light chain amyloidosis — also called AL amyloidosis — treatment, including high-dose chemotherapy with stem cell transplantation.

Amyloidosis is a rare disease that occurs when proteins in the body group together to form amyloid fibrils. The fibrils are then deposited into various tissues, including the heart, kidneys, liver and nerves. AL amyloidosis is unlike other forms of amyloidosis in that it is not hereditary.

There are many different types of amyloid medications. It's important to work with a specialist to establish the specific type of amyloidosis, so that treatment can be designed to fit each patient's needs.

AL amyloidosis is treated through a combination of chemotherapy drugs or by means of stem cell transplant. Proper treatment can improve quality of life and longevity for patients with AL amyloidosis.

Refer a patient.

Learn more about amyloidosis or schedule an appointment.

Video content outline:

  •          Introduction
  •          What is AL amyloidosis? (0:29)
  •          How to treat AL amyloidosis (4:30)
  •          What to do if diagnosed with amyloidosis (17:04)
  •          Conclusion (18:36)


July 27, 2017

Created by

Mayo Clinic

Related Presenters